Given its pivotal role in angiogenesis, the dysregulation of VEGFR-2 signaling is implicated in various pathological conditions, particularly cancer, where excessive angiogenesis fuels tumor growth and metastasis [10,11,12]. Here, KDR is linked to cancer.